The sellers side is pretty tight, I am glad the company has cash in the bank and they can do a lot of work before they ask for money again.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025